Term: carboplatin-paclitaxel-bevacizumab regimen

Pronunciation: (KAR-boh-pla-tin-PA-klih-TAK-sil-beh-vuh-SIH-zoo-mab REH-jih-men)

Description:

A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-Taxol-bevacizumab regimen.